Centre de Documentation Gilly
HORAIRE
Lu : 8h30 à 12h00
Ma : 8h15 à 12h00 - 12h30 à 16h00
Me : 8h30 à 12h00 - 12h30 à 16h00
Je : 8h30 à 12h00
Ve : 8h15 à 12h00 - 12h30 à 16h00
Bienvenue sur le catalogue du centre de documentation de Gilly
HELHa - Paramédical.
[article]
Titre : |
PET/CT in multiple myeloma |
Titre original : |
PET/CT dans les myélomes multiples |
Type de document : |
texte imprimé |
Auteurs : |
Cristina Nanni |
Année de publication : |
2017 |
Article en page(s) : |
p. 216-220 |
Langues : |
Anglais (eng) |
Mots-clés : |
MYÉLOME IMAGERIE MÉDICALE |
Résumé : |
Multiple myeloma is a plasma cell dyscrasia producing bone lytic lesions. In recent years, a wide spectrum of therapeutic approaches are available to treat the disease: an accurate therapy assessment has become, therefore, of utmost importance. In this field, imaging is becoming a cornerstone, especially in association to clinical parameters. Among imaging procedures, FDG PET/CT is recognized to provide reliable information, achieved in a very safe and fast procedure. Literature is producing very concordant results from different groups assessing the value of FDG PET/CT as a prognostic factor in general and in therapy assessment, but some issues remain regarding a standardization of image interpretation especially in borderline cases. So far, no data regarding nor other imaging compounds and the use of hybrid tomographs PET/MR are available to define therapy assessment in PET. |
Permalink : |
http://cdocs.helha.be/pmbgilly/opac_css/index.php?lvl=notice_display&id=52902 |
in MÉDECINE NUCLÉAIRE > vol. 41, n° 3 (Mai/Juin 2017) . - p. 216-220
[article] PET/CT in multiple myeloma = PET/CT dans les myélomes multiples [texte imprimé] / Cristina Nanni . - 2017 . - p. 216-220. Langues : Anglais ( eng) in MÉDECINE NUCLÉAIRE > vol. 41, n° 3 (Mai/Juin 2017) . - p. 216-220
Mots-clés : |
MYÉLOME IMAGERIE MÉDICALE |
Résumé : |
Multiple myeloma is a plasma cell dyscrasia producing bone lytic lesions. In recent years, a wide spectrum of therapeutic approaches are available to treat the disease: an accurate therapy assessment has become, therefore, of utmost importance. In this field, imaging is becoming a cornerstone, especially in association to clinical parameters. Among imaging procedures, FDG PET/CT is recognized to provide reliable information, achieved in a very safe and fast procedure. Literature is producing very concordant results from different groups assessing the value of FDG PET/CT as a prognostic factor in general and in therapy assessment, but some issues remain regarding a standardization of image interpretation especially in borderline cases. So far, no data regarding nor other imaging compounds and the use of hybrid tomographs PET/MR are available to define therapy assessment in PET. |
Permalink : |
http://cdocs.helha.be/pmbgilly/opac_css/index.php?lvl=notice_display&id=52902 |
| ![PET/CT in multiple myeloma vignette](http://cdocs.helha.be/pmbgilly/opac_css/getimage.php?url_image=http%3A%2F%2Fimages-eu.amazon.com%2Fimages%2FP%2F%21%21isbn%21%21.08.MZZZZZZZ.jpg¬icecode=&vigurl=http%3A%2F%2Fwww.em-consulte.com%2FgetInfoProduit%2FMEDNUC%2Fcouverture%2FH135_cover.jpg) |
Exemplaires (1)
|
Revue | Revue | Centre de documentation HELHa paramédical Gilly | Salle de lecture - Rez de chaussée - Armoire à volets | Exclu du prêt |